Laird Norton Trust Company, LLC Edwards Lifesciences Corp Transaction History

Laird Norton Trust Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$86.5 - $128.27 $305,431 - $452,921	-3,531 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$101.96 - $128.34 $10,094 - $12,705	-99 Reduced 2.73%	3,531 $415,000
Q4 2021 Feb 07, 2022	SELL	$106.37 - $130.68 $15,636 - $19,209	-147 Reduced 3.89%	3,630 $470,000
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $12,966 - $15,466	126 Added 3.45%	3,777 $427,000
Q2 2021 Aug 09, 2021	SELL	$83.84 - $104.76 $5,449 - $6,809	-65 Reduced 1.75%	3,651 $378,000
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $11,565 - $13,328	147 Added 4.12%	3,716 $337,000
Q4 2020 Feb 26, 2021	BUY	$71.69 - $91.23 $255,861 - $325,599	3,569 New	3,569 $326,000

1,353

466M

2.45M

2.56M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Laird Norton Trust Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Laird Norton Trust Company, LLC with notifications on news.